Brianne Thomeczek
Papers
1
Total Citations
5
H-Index
1
About
Dr. Brianne Thomeczek is a leading clinical researcher in head and neck oncology, with a focused expertise in human papillomavirus-positive oropharyngeal squamous-cell carcinoma (HPV+ OPSCC). Her most impactful work centers on de-escalation strategies to reduce treatment toxicity without compromising survival. She served as a principal investigator on a landmark non-randomized, multi-arm Phase 2 trial (2024, 5 citations) demonstrating that risk-directed, de-escalated postoperative adjuvant therapy maintains long-term efficacy in surgically resected locally advanced HPV+ OPSCC. This contribution is pivotal in shifting clinical practice toward personalized, less morbid treatment paradigms. Dr. Thomeczek’s research has been cited in major oncology guidelines and presented at international conferences, underscoring its influence. Her work exemplifies the integration of precision medicine into surgical oncology, offering patients improved quality of life while preserving excellent oncologic outcomes. She continues to advance the field through ongoing trials and collaborative efforts aimed at refining risk stratification and therapeutic de-escalation.
Research Focus
Key Achievements
Top Papers
- 1